Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF FINANCING EXPENSES (Details)

v3.21.2
SCHEDULE OF FINANCING EXPENSES (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Modification of terms relating to straight loan transaction $ 88
Modification of terms relating to convertible bridge loans transactions (7,334) (3,495)
Exchange differences relating to loans from shareholders (43) 40
Issuance of ordinary shares and stock warrants upon modification of terms relating to convertible bridge loans transactions   415   415
Issuance of shares as a settlement in excess of the carrying amount of financial liabilities 734 1,234
Amortization of discounts and accrued interest on convertible bridge loans 4,432 10,896 18,080 8,393
Amortization of discounts and accrued interest on straight loans 1,637 2,290
Change in fair value of derivative warrants liability and fair value of warrants expired (5) (299)
Change in fair value of liability related to conversion feature of convertible bridge loans 530 (3,777)
Issuance of shares as call options to acquire potential acquire 1,000 3,000
Settlement in cash of prepayment obligation related to convertible bridge loan 182   182  
Interest and related royalties under receivables financing facility 495 633 546 633
Amortization of prepaid expenses related to commitment shares in connection with receivables financing facility and equity line 293 293 61
Exchange rate differences and other finance expenses (689) 754 250 1,094
Financing (income) expenses, net $ 6,875 $ 7,055 $ 17,360 $ 11,375